BTGIN Co., Ltd.
FDA import alert and refusal historyYuseong, South KoreaFEI 3009574206
As of October 26, 2026, BTGIN Co., Ltd. is not on any FDA import alert in SupplierRadar's records; FDA refused 2 of its shipment lines between August 7, 2018 and March 28, 2023, most often for not identified as a dietary supplement (DIETARYLBL).
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- Not listed
- Last import refusal
- Ginseng, dried or paste (root & tuber vegetable) · DIRECTIONS
- Last warning letter
- None found
- Last inspection
- Classified VAI (Voluntary Action Indicated)
Every FDA record for BTGIN Co., Ltd.
3 records, newest first. Each line links to the FDA page it came from.
2026
- InspectionInspection classified VAI (Voluntary Action Indicated)Food Composition, Standards, Labeling and Econ; Foodborne Biological HazardsSource
2023
- Import refusalRefused, Ginseng, dried or paste (root & tuber vegetable)DIRECTIONSUNAPPROVEDEntry BDN-0185207-3Source
2018
- Import refusalRefused, Ginseng unconventional dietary speciality for humans or animalsDIETARYLBLFALSENO ENGLISHNUTRIT LBLEntry AEK-4982943-2Source
Refusal charges, in plain English
- DIETARYLBL1 refused line
Not identified as a dietary supplement
The label appeared not to identify the product with the term "dietary supplement" (which may be modified with the name of an ingredient).
- DIRECTIONS1 refused line
DIRECTIONS
- FALSE1 refused line
False or misleading labeling
The labeling appeared to be false or misleading in some particular.
- NO ENGLISH1 refused line
Required label information not in English
Information that must appear on the label appeared not to be given in English, or not to be repeated in every language used on the label.
- NUTRIT LBL1 refused line
Nutrition information missing from label
The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.
- UNAPPROVED1 refused line
Unapproved new drug
The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.
Questions about BTGIN Co., Ltd.
- Is BTGIN Co., Ltd. on an FDA import alert?
- No listing for BTGIN Co., Ltd. appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the South Korea page.
- Has FDA refused shipments from BTGIN Co., Ltd.?
- Yes. FDA refused 2 shipment lines from BTGIN Co., Ltd. between August 7, 2018 and March 28, 2023. The most recent, on March 28, 2023, was ginseng, dried or paste (root & tuber vegetable), charged as DIRECTIONS (directions).
- Why did FDA refuse BTGIN Co., Ltd.'s shipments?
- The most frequent charges are DIETARYLBL (not identified as a dietary supplement, 1 line) and DIRECTIONS (directions, 1 line).
- When was BTGIN Co., Ltd. last inspected by FDA?
- FDA's most recent inspection of BTGIN Co., Ltd. with a final classification is dated August 21, 2026 and was classified VAI (Voluntary Action Indicated).
- What is BTGIN Co., Ltd.'s FEI number?
- BTGIN Co., Ltd.'s FDA Establishment Identifier (FEI) is 3009574206.
Buying from BTGIN Co., Ltd.?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.